Abstract
Lung transplantation (LTx) and allogeneic hematopoietic stem cell transplantation (HSCT) are therapeutic options for advanced lung diseases and hematological disorders, respectively. Although they are effective procedures, they are associated with complications, which can limit long-term survival. In this context, chronic graft dysfunction (CGD) is a common cause of reduced survival in Tx…